Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/1998
08/26/1998CN1191491A 结缔组织生长因子 Connective tissue growth factor
08/26/1998CN1191487A Method for inhibiting vascular smooth muscle cell migration
08/26/1998CN1191481A Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
08/26/1998CN1191111A Process for preparing pharmaceutical composition containing N-acyl-2,3-benzodiazepine derivatives as active ingredient
08/26/1998CA2230349A1 Sulfonamide-substituted fused 7-membered ring compounds, processes for their preparation, their use as a medicament or diagnostic, and pharmaceutical preparations comprising them
08/25/1998US5798448 AL-1 neurotrophic factor antibodies
08/25/1998US5798375 Treatment of arteriosclerosis and xanthoma
08/25/1998US5798373 Tri-substituted phenyl derivatives useful as PDE IV inhibitors
08/25/1998US5798372 Method for preventing onset of restenosis after angioplasty employing a retinoid
08/25/1998US5798367 Indazolecarboxamides
08/25/1998US5798362 Useful as alpha-adrenoreceptor blockers; condensation
08/25/1998US5798357 Thromboxane synthetase inhibitors
08/25/1998US5798352 Antithrombotic amidinotetrahydropyridylalanine derivatives
08/25/1998US5798351 Useful for inhibiting bone loss, lowering seum cholesterol levels and treating hormone dependent mammalian breast and uterine cancer
08/25/1998US5798248 Recombinant mutant thrombin receptor and related pharmaceuticals
08/25/1998US5798102 Beta-amyloyd, streptolysin o, growth hormone
08/25/1998CA2086247C Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using
08/25/1998CA2077420C Imidazoindolizine derivatives and process for preparation thereof
08/25/1998CA2071193C Sulfonamides
08/20/1998WO1998036075A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof
08/20/1998WO1998036002A1 Cross-linked vinyl polymers with bile acid adsorbing effect
08/20/1998WO1998035979A1 Oligomers which inhibit expression of collagen genes
08/20/1998WO1998035977A1 Benzimidazole derivatives
08/20/1998WO1998035967A2 Biazacyclic crf antagonists
08/20/1998WO1998035963A1 Process for preparing eprosartan
08/20/1998WO1998035962A1 Process for preparing eprosartan
08/20/1998WO1998035959A1 Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
08/20/1998WO1998035957A1 Amide derivatives as selective neuropeptide y receptor antagonists
08/20/1998WO1998035956A1 Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
08/20/1998WO1998035949A1 Bicyclic amino acids
08/20/1998WO1998035941A1 New benzolactam derivatives and medicinal compositions containing the same
08/20/1998WO1998035937A1 Cetp activity inhibitors
08/20/1998WO1998035691A1 Treatment of infarcts through inhibition of nf-kappab
08/20/1998DE19705963A1 Vernetzte Vinylpolymere mit Gallensäure-Adsorberwirkung Networked vinyl polymers with bile acid Adsorberwirkung
08/20/1998DE19705450A1 Bicyclische aromatische Aminosäuren Bicyclic aromatic amino acids
08/20/1998CA2281602A1 Cross-linked vinyl polymers with bile acid adsorbing effect
08/20/1998CA2281525A1 Biazacyclic crf antagonists
08/20/1998CA2281224A1 Treatment of infarcts through inhibition of nf-kappab
08/20/1998CA2281086A1 Oligomers which inhibit expression of collagen genes
08/20/1998CA2280761A1 Benzimidazole derivatives
08/20/1998CA2280209A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof
08/20/1998CA2251368A1 Amide derivatives as selective neuropeptide y receptor antagonists
08/20/1998CA2229947A1 Sulfonamide-substituted chromans, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
08/19/1998EP0859054A1 Drug binding protein
08/19/1998EP0859053A1 Novel G-protein coupled receptor (HTADX50)
08/19/1998EP0858742A2 Nitrate-free powdered fruits or vegetables and manufacturing process therefor
08/19/1998EP0858459A1 Novel acid pyrazole derivatives, preparation method therefor, use thereof as drugs, novel use therefor, and pharmaceutical compositions containing such derivatives
08/19/1998EP0858457A1 5-membered heterocycles, pharmaceutical agents containing said compounds and the use thereof and methods of producing them
08/19/1998EP0858346A1 Expression of cyclin g1 in tumors
08/19/1998EP0858338A1 Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use
08/19/1998EP0696291B1 Pyrido(1,2,3-de)quinoxaline derivatives, process for preparing the same and their use in medicaments
08/19/1998CN1190967A Heterocyclylcarboxamide derivatives and their use as therapeutic agents
08/19/1998CN1190890A Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method thereof, use thereof as drugs, and pharmaceutical compositions containing said salts
08/19/1998CA2223020A1 Human protein kinase hoacf72
08/18/1998US5795905 CRF receptor antagonists and methods relating thereto
08/18/1998US5795903 Anticonvulsants, antianxiety, schizophrenia, sleep disorders, brain disorders and alzheimer's or parkinson's disease
08/18/1998US5795896 Consisting of thrombin inhibitor and absorption inhibiting agent
08/18/1998US5795883 Tocopherol or trolox group
08/18/1998US5795875 Therapeutic methods of using O-desulfated heparin derivatives
08/18/1998US5795865 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
08/18/1998US5795758 DNA encoding histidyl tRNA synthetase variant from Streptococcus pneumoniae
08/18/1998US5795575 Topical medicament which increases the number of capillaries in damaged skin
08/18/1998US5795574 Use of an extract from a non-photosynthetic filamentous bacterium and composition containing it
08/18/1998CA2224123A1 Nucleic acid construct for the cell cycle regulated expression of structural genes
08/18/1998CA2215920A1 Drug binding protein
08/18/1998CA2161768C 3-(indol-3-yl) propenoic acid derivatives and as nmda antagonists
08/18/1998CA1340007C Linear analogs of atrial natruiretic peptides
08/13/1998WO1998035055A1 Method for identifying selective inhibitors of nitric oxide synthase
08/13/1998WO1998035020A2 Methods for modulating hematopoiesis and vascular growth
08/13/1998WO1998034959A1 Dermatan disulfate, an inhibitor of thrombin generation and complement activation
08/13/1998WO1998034955A1 No-modified hemoglobins and uses therefor
08/13/1998WO1998034935A1 Fibrinogen receptor antagonist prodrugs
08/13/1998WO1998034929A1 Il-8 receptor antagonists
08/13/1998WO1998034921A1 Bicyclic inhibitors of protein farnesyl transferase
08/13/1998WO1998034920A1 2-amino substituted pyridines for use in the treatment of arteriosclerosis and hyperlipoproteinaemia
08/13/1998WO1998034919A1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
08/13/1998WO1998034895A1 5-hydroxyalkyl substituted phenyls and their use in medicaments for the treatment of arteriosclerosis and hyperlipoproteinaemia
08/13/1998WO1998034647A1 Arginine silicate inositol complex and use thereof
08/13/1998WO1998034619A1 Method for the treatment of atherosclerosis and vascular injury by prevention of vascular smooth muscle cell proliferation
08/13/1998WO1998034615A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime
08/13/1998WO1998034583A2 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones
08/13/1998WO1998030693A3 Tumor necrosis factor receptor 5
08/13/1998WO1998011206A3 THERAPY FOR α-GALACTOSIDASE A DEFICIENCY
08/13/1998CA2280181A1 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones
08/13/1998CA2280048A1 Il-8 receptor antagonists
08/13/1998CA2279927A1 Fibrinogen receptor antagonist prodrugs
08/13/1998CA2279636A1 2-amino substituted pyridines for use in the treatment of arteriosclerosis and hyperlipoproteinaemia
08/13/1998CA2279531A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime
08/13/1998CA2279233A1 Arginine silicate complex and use thereof
08/13/1998CA2278784A1 No-modified hemoglobins and uses therefor
08/13/1998CA2277022A1 Method for the treatment of atherosclerosis and vascular injury by prevention of vascular smooth muscle cell proliferation
08/13/1998CA2273895A1 Bicyclic inhibitors of protein farnesyl transferase
08/12/1998EP0857781A2 Human endoglingene promoter and use thereof
08/12/1998EP0857724A1 Sulfonamide substituted compounds, process for their preparation, their use as medicine or for diagnostic purpose
08/12/1998EP0825848A4 Novel collagen formulations
08/12/1998EP0751947B1 Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity
08/12/1998EP0701450B1 Recombinant viruses and their use in gene therapy
08/12/1998EP0696275B1 Vitamin d amide derivatives
08/12/1998EP0689538B1 Hydroxamic acid derivatives as metalloproteinase inhibitors
08/12/1998EP0596891B1 Aminoalkyl-substituted 2-amino-5-mercaptothiadiazoles, their preparation and their use
1 ... 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 ... 1595